Clearance Summary
Parsortix PC1 Device received FDA 510(k) clearance under submission number DEN200062, sponsored by Angle Europe , Ltd.. The device was reviewed via the Direct premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 2022-05-24.
- Submission: DEN200062
- Applicant / Sponsor: Angle Europe , Ltd.
- Clearance pathway: Direct
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.6110
- Decision date: 2022-05-24
Classification & Regulation
This clearance is catalogued under FDA product code QSA and 21 CFR 866.6110, within the Immunology review panel as a Class II device.